Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nuclear Stability03:18

Nuclear Stability

23.0K
Protons and neutrons, collectively called nucleons, are packed together tightly in a nucleus. With a radius of about 10−15 meters, a nucleus is quite small compared to the radius of the entire atom, which is about 10−10 meters. Nuclei are extremely dense compared to bulk matter, averaging 1.8 × 1014 grams per cubic centimeter. If the earth’s density were equal to the average nuclear density, the earth’s radius would be only about 200 meters.
To hold positively charged protons together...
23.0K
Nuclear Fusion02:45

Nuclear Fusion

33.7K
The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.7K
Non-nuclear Inheritance01:29

Non-nuclear Inheritance

23.1K
Most DNA resides in the nucleus of a cell. However, some organelles in the cell cytoplasm⁠—such as chloroplasts and mitochondria⁠—also have their own DNA. These organelles replicate their DNA independently of the nuclear DNA of the cell in which they reside. Non-nuclear inheritance describes the inheritance of genes from structures other than the nucleus.
23.1K
Nuclear Transmutation03:20

Nuclear Transmutation

20.6K
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed...
20.6K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

8.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.7K
Nuclear Power02:36

Nuclear Power

9.4K
Controlled nuclear fission reactions are used to generate electricity. Any nuclear reactor that produces power via the fission of uranium or plutonium by bombardment with neutrons has six components: nuclear fuel consisting of fissionable material, a nuclear moderator, a neutron source, control rods, reactor coolant, and a shield and containment system.
Nuclear Fuels
Nuclear fuel consists of a fissile isotope, such as uranium-235, which must be present in sufficient quantity to provide a...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Boron neutron capture therapy for recurrent pediatric sialoblastoma: the first clinical experience and dosimetric considerations for skeletal safety with 4-year follow-up.

Radiation oncology journal·2026
Same author

Comparative biological evaluation of [<sup>18</sup>F]fluciclovine, [<sup>18</sup>F]FBPA-Fr, and [<sup>18</sup>F]FET for boron neutron capture therapy: Preclinical validation and clinical feasibility.

Nuclear medicine and biology·2026
Same author

An intra-locked RNA G-quadruplex topology confers enhanced nuclease resistance and cancer cell targeting.

International journal of biological macromolecules·2026
Same author

Boron neutron capture therapy plus bevacizumab versus bevacizumab alone in recurrent glioblastoma: A propensity score-matched analysis.

Neuro-oncology advances·2026
Same author

Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.

EJNMMI research·2026
Same author

Global cognitive dysfunction and <i>β</i>-amyloid neuropathology in late-life and treatment-resistant major depression.

Psychological medicine·2026

Related Experiment Video

Updated: Jan 25, 2026

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan
07:55

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

Published on: August 27, 2019

7.9K

Nuclear Theranostics in Taiwan.

Ko-Han Lin1, Yi-Wei Chen2, Rheun-Chuan Lee3

  • 11Department of Nuclear Medicine, Taipei Veterans General Hospital, No.201, Section 2, Shipai Rd., Beitou Dist., Taipei City, Taiwan Republic of China.

Nuclear Medicine and Molecular Imaging
|May 7, 2019
PubMed
Summary

Boron neutron capture therapy (BNCT) and Y-90 radioembolization are advanced cancer treatments. Theranostic nuclear medicine imaging is crucial for patient selection and treatment assessment in these therapies.

Keywords:
BNCTFBPA-PETRadioembolizationTc-MAA

More Related Videos

Production of Synthetic Nuclear Melt Glass
04:36

Production of Synthetic Nuclear Melt Glass

Published on: January 4, 2016

9.9K
Isolation of CA1 Nuclear Enriched Fractions from Hippocampal Slices to Study Activity-dependent Nuclear Import of Synapto-nuclear Messenger Proteins
10:03

Isolation of CA1 Nuclear Enriched Fractions from Hippocampal Slices to Study Activity-dependent Nuclear Import of Synapto-nuclear Messenger Proteins

Published on: August 10, 2014

12.5K

Related Experiment Videos

Last Updated: Jan 25, 2026

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan
07:55

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

Published on: August 27, 2019

7.9K
Production of Synthetic Nuclear Melt Glass
04:36

Production of Synthetic Nuclear Melt Glass

Published on: January 4, 2016

9.9K
Isolation of CA1 Nuclear Enriched Fractions from Hippocampal Slices to Study Activity-dependent Nuclear Import of Synapto-nuclear Messenger Proteins
10:03

Isolation of CA1 Nuclear Enriched Fractions from Hippocampal Slices to Study Activity-dependent Nuclear Import of Synapto-nuclear Messenger Proteins

Published on: August 10, 2014

12.5K

Area of Science:

  • Nuclear medicine
  • Radiation oncology
  • Oncology

Background:

  • Boron neutron capture therapy (BNCT) and Y-90 radioembolization are innovative treatments for brain and liver cancers.
  • Theranostic nuclear medicine plays a vital role in patient eligibility and treatment planning for these advanced radiation therapies.
  • Accurate imaging is essential for simulating radiation doses and evaluating treatment effectiveness.

Purpose of the Study:

  • To present single-institute experiences with BNCT and Y-90 radioembolization.
  • To highlight the associated theranostic nuclear medicine approaches used at Taipei Veterans General Hospital.
  • To share insights from a leading center in Taiwan for these specialized therapies.

Main Methods:

  • Review of clinical cases undergoing BNCT and Y-90 radioembolization.
  • Description of theranostic nuclear medicine imaging protocols used for patient selection and treatment monitoring.
  • Analysis of treatment planning and efficacy assessment methodologies.

Main Results:

  • Taipei Veterans General Hospital is the sole institution in Taiwan performing BNCT.
  • The hospital is a leading center for Y-90 radioembolization in Taiwan.
  • Established theranostic nuclear medicine workflows support patient management for both therapies.

Conclusions:

  • Single-institute experience demonstrates the feasibility and importance of theranostic nuclear medicine in BNCT and Y-90 radioembolization.
  • Taipei Veterans General Hospital's expertise provides a valuable model for implementing these advanced cancer therapies.
  • Theranostic approaches are integral to optimizing patient outcomes in advanced radiation oncology.